BROOKS LABORATORIES LTD. - 533543 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Rajesh MahajanDesignation :- Managing Director / Whole Time Director BROOKS LABORATORIES LTD. - 533543 - Closure of Trading Window
Intimation for closure of trading window for the 1st quarter ended 30.06.2022 BROOKS LABORATORIES LTD. - 533543 - Related Party Disclosure For The Half Year Ended 31.03.2022
related party disclosure for the half year ended 31.03.2022 BROOKS LABORATORIES LTD. - 533543 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Financials for the quarter and financial year ended 31.03.2022 BROOKS LABORATORIES LTD. - 533543 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Announcement under Regulation 30 of SEBI(LODR), Regulations, 2015_Resignation of Company Secretary & Compliance Officer BROOKS LABORATORIES LTD. - 533543 - Audited Standalone And Consolidated Financial Results For The 4Th Quarter And Financial Year Ended 31.03.2022
Audited Standalone and Consolidated Financial Results for the 4th quarter and financial year ended 31.03.2022 BROOKS LABORATORIES LTD. - 533543 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial Year ended 31.03.2022 BROOKS LABORATORIES LTD. - 533543 - Received Marketing Authorization In UK By MHRA For Meropenem Injection 1 Gm And 500 Mg By Brooks Steriscience Limited, Subsidiary Of The Company
Received Marketing Authorization in UK by MHRA for Meropenem Injection 1 gm and 500 mg by Brooks Steriscience Limited, Subsidiary of the Company BROOKS LABORATORIES LTD. - 533543 - Board Meeting Intimation for Approval Of Audited Financial Results Of The Company
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve Approval of Audited Financial Results of the Company for the 4th quarter and financial year ended 31st March, 2022